R. Gruber James's most recent trade in Eton Pharmaceuticals Inc was a trade of 38,621 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eton Pharmaceuticals Inc | James R. Gruber | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 38,621 | 38,621 | - | - | Employee Stock Option (Right to Buy) | |
| Eton Pharmaceuticals Inc | James R. Gruber | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 25,876 | 25,876 | - | - | Restricted Stock Units | |
| Eton Pharmaceuticals Inc | R. Gruber James | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 144,677 | 374,763 | - | - | Stock Option (Right to buy) | |
| Eton Pharmaceuticals Inc | James R. Gruber | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 100,086 | 200,086 | - | - | Stock Option (right to buy) | |
| Eton Pharmaceuticals Inc | James R. Gruber | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2022 | 40,000 | 40,000 | - | - | Restricted Stock Units |